{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:20:11Z","timestamp":1788906011141,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.joms.2008.01.026","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T17:45:53Z","timestamp":1208454353000},"page":"839-847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":264,"title":["Inhibition of Oral Mucosal Cell Wound Healing by Bisphosphonates"],"prefix":"10.1016","volume":"66","author":[{"given":"Regina","family":"Landesberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Cozin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Cremers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavroula","family":"Kousteni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satrajit","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LeeAnn","family":"Garrett-Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikala","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2008.01.026_bib1","first-page":"377","article-title":"Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: A phase III, double-blind, comparative trial","volume":"7","author":"Rosen","year":"2001","journal-title":"Cancer J"},{"key":"10.1016\/j.joms.2008.01.026_bib2","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/jnci\/94.19.1458","article-title":"A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma","volume":"94","author":"Saad","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.joms.2008.01.026_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1634\/theoncologist.7-6-481","article-title":"The use of zoledronic acid, a novel, highly potent bisphosphonate, for the treatment of hypercalcemia of malignancy","volume":"7","author":"Major","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.joms.2008.01.026_bib4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/107327480200900605","article-title":"The use of bisphosphonates in patients with breast cancer","volume":"9","author":"Van Poznak","year":"2002","journal-title":"Cancer Control"},{"key":"10.1016\/j.joms.2008.01.026_bib5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2008.01.026_bib6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2008.01.026_bib7","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: Risk factors, recognition, prevention and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofacial Surg"},{"key":"10.1016\/j.joms.2008.01.026_bib8","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphonates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2008.01.026_bib9","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","article-title":"Osteonecrosis of the jaws associated with cancer chemotherapy","volume":"61","author":"Wang","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2008.01.026_bib10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.joms.2003.11.003","article-title":"Bisphosphonates and bone necrosis","volume":"62","author":"Pogrel","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2008.01.026_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.amjmed.2004.04.015","article-title":"Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: A new clinical entity","volume":"117","author":"Lugassy","year":"2004","journal-title":"Am J Med"},{"issue":"suppl","key":"10.1016\/j.joms.2008.01.026_bib12","doi-asserted-by":"crossref","first-page":"8528","DOI":"10.1200\/jco.2006.24.18_suppl.8528","article-title":"Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy","volume":"24","author":"Hoff","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2008.01.026_bib13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.joms.2008.01.026_bib14","doi-asserted-by":"crossref","first-page":"43603","DOI":"10.1074\/jbc.M308114200","article-title":"Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: Evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B\/Akt","volume":"278","author":"Bezzi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.joms.2008.01.026_bib15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.bbrc.2003.09.083","article-title":"A novel non-containing-nitrogen bisphosphonate inhibits both in vitro and in vivo angiogenesis","volume":"310","author":"Hamma-Kourbali","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.joms.2008.01.026_bib16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1172\/JCI200422087","article-title":"An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis","volume":"114","author":"Giraudo","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.joms.2008.01.026_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0006-291X(02)02218-0","article-title":"Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro","volume":"297","author":"Okamoto","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.joms.2008.01.026_bib18","first-page":"1080","article-title":"Pamidronate induces modifications of circulating angiogenetic factors in cancer patients","volume":"8","author":"Santini","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.joms.2008.01.026_bib19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2008.01.026_bib20","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2007.12.1269","article-title":"American Society of Clinical Oncology","volume":"25","author":"Kyle","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2008.01.026_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/jop.2006.2.1.7","article-title":"Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer","volume":"1","author":"Ruggiero","year":"2006","journal-title":"J Oncol Prac"},{"key":"10.1016\/j.joms.2008.01.026_bib22","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: Report of a Task Force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2008.01.026_bib23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/jps.2600830521","article-title":"Cytotoxic effects of pamidronate on monolayers of human intestinal epithelial (Caco-2) cells and its epithelial transport","volume":"83","author":"Twiss","year":"1994","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.joms.2008.01.026_bib24","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1359\/jbmr.1999.14.5.784","article-title":"The effects of nitrogen-containing bisphosphonates on human epithelial (Caco-2) cells, an in vitro model for intestinal epithelium","volume":"14","author":"Twiss","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2008.01.026_bib25","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1046\/j.1365-2036.1999.00658.x","article-title":"Bisphosphonates cause gastric epithelial injury independent of effects on the microcirculation","volume":"13","author":"Wallace","year":"1999","journal-title":"Alimen Pharmacol Ther"},{"key":"10.1016\/j.joms.2008.01.026_bib26","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S8756-3282(01)00589-0","article-title":"Nitrogen-containing bisphosphonates induce apoptosis of Caco-2 cells in vitro by inhibiting the mevalonate pathway: A model of bisphosphonate-induced gastrointestinal toxicity","volume":"29","author":"Suri","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.joms.2008.01.026_bib27","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJM199610033351403","article-title":"Esophagitis associated with the use of alendronate","volume":"335","author":"de Groen","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2008.01.026_bib28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1601-0825.2005.01117.x","article-title":"Apoptosis in normal and diseased oral tissues","volume":"11","author":"Loro","year":"2005","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2008.01.026_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jss.2006.07.034","article-title":"Screening and detection of apoptosis","volume":"139","author":"Huerta","year":"2007","journal-title":"J Surg Res"},{"key":"10.1016\/j.joms.2008.01.026_bib30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35077213","article-title":"Proliferation, cell cycle and apoptosis in cancer","volume":"411","author":"Evan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.joms.2008.01.026_bib31","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jnci\/84.10.788","article-title":"Pharmacokinetics of pamidronate in patients with bone metastases","volume":"84","author":"Leyvraz","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.joms.2008.01.026_bib32","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1359\/JBMR.050522","article-title":"Skeletal retention of bisphosphonate (palmidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metstasis","volume":"20","author":"Cremers","year":"2005","journal-title":"J Bone Mineral Res"},{"key":"10.1016\/j.joms.2008.01.026_bib33","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","volume":"41","author":"Reid","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.joms.2008.01.026_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0378-4347(95)00531-5","article-title":"Extraction and measurement of pamidronate from bone samples using automated pre-column derivatization, high-performance liquid chromatography and fluorescence detection","volume":"678","author":"King","year":"1996","journal-title":"J Chromatogr B Biomed Appl"},{"key":"10.1016\/j.joms.2008.01.026_bib35","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/BF02555853","article-title":"The pharmacokinetics and distribution of pamidronate for a range of doses in the mouse","volume":"49","author":"Hoggarth","year":"1991","journal-title":"Calcif Tissue Int"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239108000943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239108000943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:21:56Z","timestamp":1759508516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239108000943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0278239108000943"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2008.01.026","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Oral Mucosal Cell Wound Healing by Bisphosphonates","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2008.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}